Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Proove Biosciences Continues to Expand Salesforce
  • USA - English


News provided by

Proove Biosciences

Mar 30, 2016, 09:00 ET

Share this article

Share toX

Share this article

Share toX


We are proud that Proove is the only company with a portfolio of patented testing which that identifies patient pain sensitivity and risk for opioid abuse to stand the test of time while delivering ongoing value for patients and doctors.

Post this

Irvine, CA (PRWEB) March 30, 2016 -- Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, is excited to announce the expansion of its salesforce. Building on record growth, Proove Biosciences is expanding its network of authorized distributors and independent sales representatives across the United States. The expansion underscores the company’s steady rise to prominence during a challenging economic environment. Founded in 2009, Proove Biosciences quickly emerged as a leader in precision medicine, opening offices in both Maryland and California. “Over the past six years, many companies attempted to provide offer just one of our tests –- drug metabolism genetic testing—only to have gone out of business shortly thereafter,”says Brian Meshkin, CEO at Proove Biosciences. “We are proud that Proove is the only company with a portfolio of patented testing which that identifies patient pain sensitivity and risk for opioid abuse to stand the test of time while delivering ongoing value for patients and doctors.”

Independent Sales Representatives Drive Growth
Proove Biosciences started with a team of independent sales representatives more than six years ago—and many representatives have grown with the company. In 2012, the organization started its first expansion of independent sales representatives, which included the company’s first distributor—Joe Matthews. Matthews was an Ohio-based sales executive with 15 years of medical device and compression therapy experience. In a short time, Mathews built a team of six independent sales representatives across the nation, providing guidance that allowed each person on his to team to earn six figures annually. “It is all about just going to work and making it happen,” says Matthews. “There is such a difference between Proove and other companies who just offer drug metabolism genetic testing. Doctors can clearly see the difference.”
 
Matthews became the first authorized distributor to exceed a million dollars in annual commissions. After years of success, Joe is now the Vice President of Market Development at Proove Biosciences. Watching the company grow, Mathews reflected on the challenges in the early days. “When we started, there were many more challenges. Naturally, we made mistakes. The good news is that it is easy to teach others the business now,” explained Matthews. In the past, there was a larger discrepancy among the sales staff who had success and those who fell short of expectations. “Many sales representatives did not work the business properly. When I started, many reps were focused on test volume instead of reimbursements. As we matured as a business unit, however, we were able to integrate more robust training into our sales program, thereby making it easier for more sales representative to succeed.”

Greg Schaefer, an independent sales representative from Kentucky, emerged as another success story that reflects the unique opportunities at Proove Biosciences. “I was introduced to Proove in 2013,” said Schaefer. “For the first time in my small business’s history, I felt as though I had a partner who truly differentiated themselves from the competition—not only in personalized medicine, but also in the genetic testing field.” The ability for Proove Biosciences to differentiate itself in the marketplace is helping newer sales representatives achieve success more quickly. “I closed more than 25 accounts over the last couple of years—and the physicians within those accounts have ordered more than 35,000 tests. This is exciting because patients receive better care and doctors gain added trust from their patients,” explained Schaefer. “As for myself, earning more than $350,000 during the first 18 months appears to be only the beginning. I am very proud to be a part of the Proove team and represent such an amazing company and product line.”
 
As the company begins the year with record sales, newer sales representatives are finding it easy to experience high levels of success. In 2015, Eric Hansen joined the company with his distributorship. Within the first few months, Hansen signed several leading hospitals in the Orange County and Los Angeles area. As Hansen started with a handful of big accounts, he was able to develop a promising pipeline that looks good for future business. With a business model that provides value to both patients and doctors, Hansen believes that he has everything he needs to succeed. “Proove provides great support, which makes it easier to close large accounts like hospitals, orthopedic surgery practices, and other specialty providers.” As the first quarter comes to a close, the future looks bright for the rest of 2016—and for many of the company’s independent sales representatives. “I am so excited about what the future holds,” exclaimed Hansen.
 
Expansion of Full-Times Sales Representatives
Proove Biosciences is expanding its full-time sales staff as part of its nationwide expansion efforts. Building on its success in Southern California, the company is looking to attract talented sales representatives in Chicago, Baltimore, Atlanta, and many other areas across the nation. Proove is looking for entrepreneurial sales representatives who can work with minimal supervision in a field-based position to drive sales growth in testing, physician and institutional relationships, account management, and clinical research expansion. For more information on sales opportunities with Proove, please contact Michelle Burt at mburt(at)proove(dot)com.

About Proove Biosciences
Our mission is to change the future of medicine. Proove represents the proof to improve healthcare decisions. We seek to realize a future when clinicians look back and wonder how they could have ever prescribed medications without knowing how a patient would respond. Physicians use Proove Biosciences testing to improve outcomes—both safety and efficacy of medical treatment. From a simple cheek swab collected in the office, Proove performs proprietary genetic tests in its CLIA-certified laboratory to identify patients at risk for misuse of prescription pain medications and evaluate their metabolism of medications. For more information, please visit http://www.proove.com or call toll free 855-PROOVE-BIO (855-776-6832).

Public Relations, Proove Biosciences, http://www.proove.com, +1 949-556-7239, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.